Heart arrhythmia specialist company, Biosense Webster, Inc., has completed patient enrollment in its U.S. IDE study of the THERMOCOOL SMARTTOUCH® SF Catheter. The device is designed for the treatment of persistent atrial fibrillation (AF), an irregular heartbeat that lasts beyond seven days. AF...
Corin Group has launched its new Unity Knee™ with EquiBalance™ instrumentation at this year's...read the full article >
UK MedTech industry body, the ABHI has partnered with Southern California’s leading business...read the full article >
The First-in-Man (FIM) study of SELUTION™, Med Alliance’s novel sirolimus-coated balloon has...read the full article >
The U.S. FDA has approved an Investigational Device Exemption for the CardiAMP Chronic Myocardial...read the full article >